Skip to content
About Us
Company Profile
Management
Investors
Contact
Research & Development
Mode of Action
Clinical Development
Publications
Vascular Integrity
Sepsis & Septic Shock
Adrenomedullin
News & Events
Press releases
Media coverage
Events
Career
Menu
About Us
Company Profile
Management
Investors
Contact
Research & Development
Mode of Action
Clinical Development
Publications
Vascular Integrity
Sepsis & Septic Shock
Adrenomedullin
News & Events
Press releases
Media coverage
Events
Career
Article in InVivo: End Game: Adrenomed Targets Global Reach For Sepsis Candidate
2. April 2024
The
article
was published by David Wild, In Vivo, Citeline Commercial.